Evidence map›Paper›PMID 38106824›Full record

ReviewIranian journal of public health2023

Trends in the Antibiotic Resistance of Non-Tuberculous Mycobacteria in Iran: A Systematic Review and Meta-Analysis.

Hamid Heidari, Parisa Kalantari, Mohammad Sholeh, Sahel Hamze Pour, Atieh Darbandi, Abbas Maleki, Abbas Ghaysouri, Hossein Kazemian

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Iranian journal of public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 syntheses or guidelines pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Hamid HeidariDepartment of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Parisa KalantariDepartment of Paramedical, Faculty of Medical Sciences, Islamic Azad University, Arak, Iran.
Mohammad SholehDepartment of Microbiology, Pasteur Institute of Iran, Tehran, Iran.
Sahel Hamze PourLaboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Atieh DarbandiDepartment of Microbiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Abbas MalekiClinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Abbas GhaysouriDepartment of Internal Medicine, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Hossein KazemianClinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Ilam University · IRGolestan University · IRIran University of Medical Sciences · IRIslamic Azad University, Arak · IRMedical University of Ilam · IRPasteur Institute of Iran · IRShahid Sadoughi University of Medical Sciences and Health Services · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Non-tuberculous mycobacteria (NTM) infections have been continuously increasing as major concerns of public health in Iran. Because innate resistance of NTM species, the treatment of these infections is difficult task, but until now resistance pattern of NTM and suitable regimens are not determined. Methods: We systematically searched the relevant studies in PubMed, Scopus, and Embase (Until Dec 2022). All statistical analyses were carried out using the statistical package R. Results: Eleven studies included in the analysis were performed in 6 provinces and investigated 1223 NTM clinical species. The majority of the studies originated in Tehran. Among the first-line anti-TB drugs, almost all NTM species were highly resistant to first-line anti-TB drugs. No significant difference in the isoniazid resistance rate was found in the slow or rapid-growing species and Runyon's classification of NTM isolates. A decreased in the prevalence of ciprofloxacin, clarithromycin, and moxifloxacin resistance were showed in during 2013-2022 years. Conclusion: Most investigated antibiotics have a minor effect on NTM species and a steady increase of resistance has been seen in last few years then, need more-effective alternative regimens is clear.

Indexed as

AntibioticMeta-analysisNon-tuberculous mycobacteria (NTM)ResistanceSystematic review

Identifiers

PMID38106824
PMCPMC10719700
OpenAlexW4388608602

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.